Clinical Trial Update: Asymptomatic Congenital CMV Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating treatment for asymptomatic congenital cytomegalovirus infection was terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Congenital Cytomegalovirus Infection | Phase 2 | Status: TERMINATED | Results posted: 2023-01-26